St. Louis, Mo., USA - August 10, 2010, St. Louis, Mo., USA - K-V Pharmaceutical announced that Robert Baldini was appointed as a new independent member of the board of directors.
Article continues below
Mr. Baldini has more than 50 years of experience in the pharmaceutical industry. He is considered one of the foremost marketers of pharmaceutical products, and has been personally instrumental in the introduction of over 27 pharmaceutical products into the marketplace.
Mr. Baldini began his career at Pfizer and subsequently joined Geigy (which subsequently became Ciba-Geigy) where he worked in the company's internal advertising agency, initially in market research and product management.
Following the Ciba-Geigy merger, Mr. Baldini was promoted to head of its advertising agency (C&G Advertising), where he was instrumental in building one of the strongest advertising departments in medical advertising.
Beginning in 1981, Mr. Baldini spent 14 years with Key Pharmaceuticals. Initially, Key was a small start-up company in Florida. He began as the Vice President of Marketing and Sales and was subsequently promoted to General Manager and eventually President.
In 1986, Schering-Plough acquired Key, which became Schering's independent respiratory and cardiovascular division. Mr. Baldini stayed with the company, ultimately serving six years as President of the division.
Mr. Baldini left Key in 1995 and joined Kos Pharmaceuticals where he served as the Vice Chairman of the Board and Chief of Marketing and Sales until it was acquired in 2007 by Abbott Laboratories for over $4 billion.
Since 2005, Mr. Baldini has served as a member of the Board and consultant to Arisaph Pharmaceuticals, an emerging biopharmaceutical company focused on developing therapies for cancer, cardiovascular disease and diabetes. Mr. Baldini also served on the board of Espirit Pharma, prior to its acquisition by Allergan in 2007 for $370 million.
Currently, Mr. Baldini is also involved with two start-up organizations, Accubreak, an innovative pharmaceutical company which utilizes tablet technology for life-cycle management, and Dermworx's, a dermatological company utilizing nano-technology and drug delivery systems.
Mr. Baldini was inducted into the Medical Advertising Hall of Fame and more recently into Seton Hall University's Entrepreneur Hall of Fame. He was also named Seton Hall University's Most Distinguished Alumnus in 2000 and the Arthritis Foundation's Humanitarian of the Year in 1997. ■